Jinhe Biotechnology CO., LTD. (SHE:002688)

Market Cap	4.05B -28.2%
Revenue (ttm)	2.99B +20.9%
Net Income	38.74M -63.5%
EPS	0.05 -63.9%
Shares Out	755.68M
PE Ratio	107.91
Forward PE	n/a
Dividend	0.10 (1.87%)
Ex-Dividend Date	Jun 1, 2026

Volume	14,301,600
Open	5.22
Previous Close	5.22
Day's Range	5.22 - 5.50
52-Week Range	4.58 - 7.74
Beta	0.33
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About SHE:002688

Jinhe Biotechnology CO., LTD. produces and sells veterinary medicines in China and internationally. It offers chlortetracycline premixes; veterinary drug and powder series; disinfectants; and sprinklers. It also engages in the production and sales of feed and raw materials. The company was founded in 1990 and is headquartered in Hohhot, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1990
• Employees: 2,713
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002688

Financial Performance

In 2025, SHE:002688's revenue was 2.88 billion, an increase of 21.41% compared to the previous year's 2.37 billion. Earnings were 27.56 million, a decrease of -72.50%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Aug 20, 2026

Data Sources Report a data error